Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese

被引:17
作者
Bennetzen, M. F. [1 ]
Nielsen, T. S. [2 ]
Paulsen, S. K.
Bendix, J. [3 ]
Fisker, S. [2 ]
Jessen, N. [2 ]
Lund, S. [2 ]
Richelsen, B. [1 ]
Pedersen, S. B. [1 ]
机构
[1] Aarhus Univ Hosp, Dept Endocrinol C, DK-8000 Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Endocrinol M, DK-8000 Aarhus C, Denmark
[3] Aarhus Univ Hosp, Dept Surg, DK-8000 Aarhus C, Denmark
基金
英国医学研究理事会;
关键词
Adipose tissue; CB1; human; obesity; PCR; Western blot; CARDIOMETABOLIC RISK-FACTORS; ENDOCANNABINOID SYSTEM; OVERWEIGHT PATIENTS; EXPRESSION; RIMONABANT; CB1; DYSREGULATION; BLOCKER; WEIGHT; CELLS;
D O I
10.1111/j.1365-2362.2009.02231.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cannabinoid 1 receptors are identified in various tissues involved in the internal metabolism including adipose tissue and the endocannabinoid system is claimed to be overactive in the obese state. To study the potential involvement of cannabinoid receptor 1 in the endocannabinoid system over-activity in adipose tissue in the obese state, we investigated the cannabinoid receptor 1 levels in adipose tissue from different fat depots in lean and obese humans. Materials and methods The adipose tissue samples were analysed by Western blot and by RT-PCR. Results Both the gene expression and the protein of cannabinoid receptor 1 were lower in subcutaneous abdominal adipose tissue from obese subjects as compared with lean subjects (P < 0.01 and P = 0.058). Moreover, in lean subjects, the level of cannabinoid receptor 1 was significantly higher in subcutaneous adipose tissue compared with visceral adipose tissue (P < 0.05) for both gene expression and protein. The level of cannabinoid receptor 1 was similar between the two depots in obese subjects. The expression of cannabinoid receptor 1 was higher in subcutaneous gluteal adipose tissue as compared with subcutaneous abdominal adipose tissue (P < 0.05). Conclusion We found in lean subjects, a robust lower level of cannabinoid receptor 1 in visceral adipose tissue compared with subcutaneous adipose tissue (both RNA and protein levels), but similar levels of cannabinoid receptor 1 between the two depots in obese subjects. Our present findings do not indicate that cannabinoid receptor 1 is directly involved in the endocannabinoid system over-activity in adipose tissue in obesity.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 22 条
[1]   Enzymatic pathways that regulate endocannabinoid signaling in the nervous system [J].
Ahn, Kay ;
McKinney, Michele K. ;
Cravatt, Benjamin F. .
CHEMICAL REVIEWS, 2008, 108 (05) :1687-1707
[2]   The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells [J].
Bensaid, M ;
Gary-Bobo, M ;
Esclangon, A ;
Maffrand, JP ;
Le Fur, G ;
Oury-Donat, F ;
Soubrié, P .
MOLECULAR PHARMACOLOGY, 2003, 63 (04) :908-914
[3]   Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity [J].
Blueher, Matthias ;
Engeli, Stefan ;
Kloeting, Nora ;
Berndt, Janin ;
Fasshauer, Mathias ;
Batkai, Sandor ;
Pacher, Pal ;
Schoen, Michael R. ;
Jordan, Jens ;
Stumvoll, Michael .
DIABETES, 2006, 55 (11) :3053-3060
[4]   Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men [J].
Cote, M. ;
Matias, I. ;
Lemieux, I. ;
Petrosino, S. ;
Almeras, N. ;
Despres, J-P ;
Di Marzo, V. .
INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (04) :692-699
[5]   Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia [J].
Despres, JP ;
Golay, A ;
Sjostrom, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2121-2134
[6]  
DEVANE WA, 1988, MOL PHARMACOL, V34, P605
[7]   Activation of the peripheral endocannabinoid system in human obesity [J].
Engeli, S ;
Böhnke, J ;
Feldpausch, M ;
Gorzelniak, K ;
Janke, J ;
Bátkai, S ;
Pacher, P ;
Harvey-White, J ;
Luft, FC ;
Sharma, AM ;
Jordan, J .
DIABETES, 2005, 54 (10) :2838-2843
[8]   International Union of Pharmacology. XXVII. Classification of cannabinoid receptors [J].
Howlett, AC ;
Barth, F ;
Bonner, TI ;
Cabral, G ;
Casellas, P ;
Devane, WA ;
Felder, CC ;
Herkenham, M ;
Mackie, K ;
Martin, BR ;
Mechoulam, R ;
Pertwee, RG .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :161-202
[9]   Human adipose tissue cannabinoid receptor 1 gene expression is not related to fat cell function or adiponectin level [J].
Lofgren, Patrik ;
Sjolin, Eva ;
Wahlen, Kerstin ;
Hoffstedt, Johan .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04) :1555-1559
[10]   Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia [J].
Matias, Isabel ;
Gonthier, Marie-Paule ;
Orlando, Pierangelo ;
Martiadis, Vassilis ;
De Petrocellis, Luciano ;
Cervino, Cristina ;
Petrosino, Stefania ;
Hoareau, Laurence ;
Festy, Franck ;
Pasquali, Renato ;
Roche, Regis ;
Maj, Mario ;
Pagotto, Uberto ;
Monteleone, Palmiero ;
Di Marzo, Vincenzo .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) :3171-3180